Matches in Wikidata for { <http://www.wikidata.org/entity/Q63835424> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q63835424 description "assaig clínic" @default.
- Q63835424 description "clinical trial" @default.
- Q63835424 description "clinical trial" @default.
- Q63835424 description "clinical trial" @default.
- Q63835424 description "clinical trial" @default.
- Q63835424 description "ensaio clínico" @default.
- Q63835424 description "ensayo clínico" @default.
- Q63835424 description "ensayu clínicu" @default.
- Q63835424 description "essai clinique" @default.
- Q63835424 description "klinisch onderzoek" @default.
- Q63835424 description "клінічне випробування" @default.
- Q63835424 name "Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane" @default.
- Q63835424 type Item @default.
- Q63835424 label "Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane" @default.
- Q63835424 prefLabel "Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane" @default.
- Q63835424 P1132 Q63835424-807B84E4-2257-4F39-9F78-A50CBC006FFC @default.
- Q63835424 P1476 Q63835424-52DB651F-2236-4F45-8790-D8E4B01C9A4D @default.
- Q63835424 P17 Q63835424-BE28D0BC-1392-420B-B701-6688629C8463 @default.
- Q63835424 P1813 Q63835424-E73A051A-6F84-4A8E-9DAE-28884EFBB9B1 @default.
- Q63835424 P2899 Q63835424-4F8C346B-E744-4F73-8E23-97F53887B85F @default.
- Q63835424 P3098 Q63835424-2EB1480C-5180-4BEB-96BB-C9BABEA7C119 @default.
- Q63835424 P31 Q63835424-63A9A590-8D8A-42E6-AD35-751CB14CAD76 @default.
- Q63835424 P4844 Q63835424-73510A2E-1511-4614-9C9E-C0E2A95D754B @default.
- Q63835424 P580 Q63835424-106F77E1-986B-4F26-988B-6D8CCB6641A0 @default.
- Q63835424 P582 Q63835424-D8411881-5BD6-4AB9-9250-B5726B996703 @default.
- Q63835424 P6099 Q63835424-90C3D16D-DDE8-476D-A8BA-B481D79E5797 @default.
- Q63835424 P8363 Q63835424-AEBB92AD-4A09-4287-AACC-5E658FCB13E1 @default.
- Q63835424 P1132 "+3" @default.
- Q63835424 P1476 "A Multicenter Randomized, Double Blind, Placebo- Controlled, Phase II Study to Compare Endocrine Treatment Alone Versus Endocrine Treatment With Everolimus in Patients With HR+/HER2- Metastatic Breast Cancer and Progression After Previous Treatment With Exemestane and Everolimus" @default.
- Q63835424 P17 Q183 @default.
- Q63835424 P1813 "Evelyn" @default.
- Q63835424 P2899 "+18" @default.
- Q63835424 P3098 "NCT01773460" @default.
- Q63835424 P31 Q30612 @default.
- Q63835424 P4844 Q32089 @default.
- Q63835424 P580 "2013-07-01T00:00:00Z" @default.
- Q63835424 P582 "2014-07-01T00:00:00Z" @default.
- Q63835424 P6099 Q42824827 @default.
- Q63835424 P8363 Q78089383 @default.